Evaluation of Walgreens Company

Only available on StudyMode
  • Download(s): 38
  • Published: January 11, 2013
Read full document
Text Preview
Walgreens CO.|
Managerial finance project|

Walgreens CEO1
The board of directors2
How much trading volume is there on the stock?4
Does the firm has any has publicly traded debt?4
Societal constraint4
Liquidity ratios4
Overall risk of company8
Marginal investors in the company9
Estimate the default risk and cost of debt of your company9
Weights of debt and equity10
Evaluating the firm´s current investment12
Choice of the optimal financing mix13
Analyses of the current financing decisions14
Dividend Policy Evaluation15

Walgreens CEO
Gregory D. Wasson is the president of Walgreens, and CEO effective since February 1, 2009. Wasson joined the company as a pharmacy intern in 1980 while attending Purdue University’s school of pharmacy, and managed stores in the Houston area before being promoted to a district manager position in 1986. Wasson was promoted to a regional vice president of the store operations division in 1999. In 2001, he was promoted again to Walgreens vice president and made an executive vice president of Walgreens Health Initiatives, the company’s pharmacy benefit manager (PBM). Wasson was promoted to president of Walgreens Health Initiatives in 2002, Walgreens senior vice president in 2004 and to a Walgreens executive vice president in 2005. He was named president and chief operating officer of Walgreens in 2007. Following the departure of Jeff Rein from the position of CEO, Wasson was chosen as the new officer after a nationwide search for candidates, the first including external possibilities. He sits on the Board of Directors of the Consumer Goods Forum. Wasson, 54, received compensation valued at about $12 million for the fiscal year that ended Aug. 31, according to the Deerfield, Ill., company's annual proxy statement filed Monday. That represented a 1 percent drop compared to fiscal 2011. Wasson, who became...
tracking img